-transparent.png){kind=logo}
A 32P-postlabelling method was developed to measure cisplatin-DNA adducts. Platinated oligonucleotides with different chain lengths were enzymatically digested with deoxyribonuclease I, snake venom phosphodiesterase (SVPD) and prostatic acid phosphatase. We found that SVPD was not able to cut the phosphodiester bond immediately 5' to the platinated nucleotide. As a result the adducts had an attached 5' unmodified nucleotide, while the unmodified nucleotides were digested to nucleosides. This is a facile enrichment procedure for the adducts, because the normal nucleosides lacking the 3'-phosphate are not substrates for T4 polynucleotide kinase. Instead, the adduct fragments containing an unmodified nucleotide at their 5' end can be phosphorylated by T4 polynucleotide kinase and [-32P]ATP. This method was also shown to be suitable for the detection of cisplatin-adducts in platinated calf thymus DNA.
A Försti, and
K Hemminki
January 1991,
Bioconjugate chemistry,
A Försti, and
K Hemminki
March 1997,
Journal of chromatography. B, Biomedical sciences and applications,
A Försti, and
K Hemminki
January 1993,
IARC scientific publications,
A Försti, and
K Hemminki
April 1995,
Nucleic acids research,
A Försti, and
K Hemminki
April 2003,
Gut,
A Försti, and
K Hemminki
September 1997,
Carcinogenesis,
A Försti, and
K Hemminki
September 1990,
Carcinogenesis,
A Försti, and
K Hemminki
December 1993,
Carcinogenesis,
A Försti, and
K Hemminki
January 1993,
IARC scientific publications,
A Försti, and
K Hemminki
August 1997,
Mutation research,
